NCT04257513View on ClinicalTrials.gov

Clinical Study to Monitor Plasma Levels of 24OHC in Subject with HD

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2019

Primary Completion Date

March 6, 2023

Study Completion Date

June 2, 2023

Conditions
Huntington Disease
Interventions
DIAGNOSTIC_TEST

Brain MRI

Neurological and Cognitive evaluation; Brain MRI

Trial Locations (1)

20133

UOC Genetica Medica e Neurogenetica, Milan

All Listed Sponsors
collaborator

Istituto Di Ricerche Farmacologiche Mario Negri

OTHER

lead

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

OTHER

NCT04257513 - Clinical Study to Monitor Plasma Levels of 24OHC in Subject with HD | Biotech Hunter | Biotech Hunter